Locations:
Search IconSearch

Rheumatology & Immunology

19-CCC-6016-top10Innov-2019-1_650x450

No. 1 Medical Innovation for 2020: Dual-Acting Osteoporosis Drug

Romosozumab builds more bone than any previous medication

19-RHE-1388-osteoporosis-650×540

Romosozumab: A New Era in Osteoporosis Treatment

Dual-acting drug increases bone formation while decreasing resorption

19-RHE-1389-Adam-Brown-650×450

Educational Hurdles in a Complex Field Contribute to Workforce Shortage

A new, accessible text aims to make rheumatology more approachable for medical students

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Vaccine
October 1, 2019/Primary Care

The Return of Measles: An Unnecessary Sequel

How to cut through the noise about vaccination

19-RHE-1019-littlejohn-leukopeniaLupus-650×450

Changes of ANA Titers Over Time: Preclinical to Clinical Lupus

New grant to assess potential significance of serial ANA testing

BackPage 14 of 24Next

Advertisement

Ad